CDIXOTCServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31

Cardiff Lexington Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$0.04−0.01 (-25.53%)

Close on Oct 19, 2026

Market cap: $534.29K
P/E (TTM): –
Dividend yield: –

Cardiff Lexington Corp income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-31	FY 2006 2006-12-31
Revenue	12	8.27	12	11	9.88	3.45	3.71	2.23	1.63	1.15	1.39	0.89	0	0.00	0.00	0.00	–	–	–	–
Cost of Revenue	4.33	3.84	3.56	4.06	3.77	1.67	1.67	1.47	1.43	0.80	0.86	0.62	0	–	0	0	–	–	–	–
Gross Profit	7.21	4.43	8.29	6.63	6.11	1.78	2.04	0.76	0.19	0.35	0.39	0.24	0	–	0.00	0.00	–	–	–	–
Selling, General & Admin	5.33	4.06	3.08	2.70	4.43	3.59	3.31	2.76	2.06	2.51	–	–	–	–	–	–	–	–	–	–
Advertising Expenses	0.37	0.37	0.13	0.23	1.30	1.51	–	–	–	–	–	–	–	0.01	0.02	0.01	–	–	–	–
Operating Expenses	6.11	4.62	3.10	2.73	4.45	3.59	3.31	2.78	3.19	2.52	4.30	13	11	0.82	1.09	1.42	–	–	–	–
Operating Income	1.10	-0.19	5.20	3.91	1.66	-1.80	-1.27	-2.02	-2.99	-2.16	-3.91	-12	-11	-0.82	-1.09	-1.42	–	–	–	–
Interest Expense	6.82	3.05	0.44	0.45	–	0.14	0.49	0.33	0.11	0.05	0.03	0.06	0.51	0.52	0.91	0.33	–	–	–	–
Interest & Investment Income	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0.00	–	–	–	–	–
Income from Equity Investments	–	–	–	–	–	–	–	–	–	–	–	–	–	0.60	-2.83	–	–	–	–	–
Other Non-Operating Income	-6.85	-3.00	-2.08	-7.16	-1.97	-1.12	-5.31	-1.93	-0.66	-0.09	-0.03	-0.68	0.06	1.42	-1.75	-0.87	–	–	–	–
Asset Impairment Charges	–	–	0	2.09	0	–	0	0	0	0	0	1.41	0	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	-0.01	0	–	1.20	1.20	–	0.09	0.00	-0.04	-0.01	0.01	0	–	0.02	0	–	–	–	–	–
Pretax Income	-5.75	-3.19	3.11	-3.25	-0.30	-2.92	-6.03	–	–	–	–	–	–	–	–	–	–	–	–	–
Income Tax Expense	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Income from Continuing Operations	–	–	3.03	-5.43	0.67	-2.84	-7.18	-6.27	-3.65	–	–	–	–	–	–	–	–	–	–	–
Income from Discontinued Operations	–	–	-0.09	-2.18	0.97	0.08	-0.60	-2.31	–	–	–	–	–	–	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	-5.51	-3.30	3.03	-5.43	–	-2.84	-7.18	–	–	–	–	-13	–	–	–	–	–	–	–	–
Net Income	-5.51	-3.30	3.03	-5.43	0.67	-2.84	-7.18	-6.27	-3.65	-2.25	-3.94	-13	-11	0.60	-2.83	-2.29	-1.14	-1.90	-0.79	-1.28
Preferred Dividends	–	–	0.78	–	–	0.19	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Net Income to Common	-6.54	-4.27	2.25	-5.81	-0.41	-4.44	–	–	–	–	–	-13	-11	0.78	-2.64	–	–	–	–	–
EPS (Basic)(per share)	–	–	–	–	-2,249.91	–	–	-22,496,850.09	-283,910,248,135.80	-573,669,677,295.00	-1,754,754,307,020.00	-38,435,868,378,765.00	-1,966,607,144,317,530.00	843,631,878,375,000.00	-4,218,159,391,875,000.00	-3,374,527,513,500,000.00	–	–	–	–
EPS (Diluted)(per share)	–	–	–	–	-2,249.91	–	–	-22,496,850.09	-283,910,248,135.80	-573,669,677,295.00	-1,754,754,307,020.00	-38,435,868,378,765.00	-1,966,607,144,317,530.00	843,631,878,375,000.00	-4,218,159,391,875,000.00	-3,374,527,513,500,000.00	–	–	–	–
Shares Outstanding (Basic, Weighted)(shares)	6.93	3.82	0.00	0.00	0.00	0.00	0	0	0	0	0	0	0	0	0	0	–	–	–	–
Shares Outstanding (Diluted, Weighted)(shares)	8.50	3.82	0.01	0.00	0.00	0.00	0	0	0	0	0	0	0	0	0	0	–	–	–	–
EBITDA	1.11	-0.18	5.22	3.93	1.68	-1.78	-1.20	-1.94	-2.76	-1.99	-3.83	-12	-11	-0.80	-1.08	-1.42	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 60.4%
Operating margin: -10.9%
Net margin: -92.1%
Return on equity, FY2025: -5111.3%

Financial strength

Current ratio: 0.91
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 0.8%

Valuation

P/E ratio: –
Price to sales: 0.05
Price to book: 0.30
Dividend yield: –